13 Facts About Joy Wolfram

Joy Wolfram was born on 1989 and is a Finnish nanoscientist.

Joy Wolfram is known for her pioneering work in nanomedicine concerning the treatment of cancer, cardiovascular diseases and other life-threatening illnesses.

Joy Wolfram is an associate professor at the University of Queensland, in the school of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology.

Joy Wolfram is an affiliate faculty member at Houston Methodist Hospital's Department of Nanomedicine.

Joy Wolfram's father is Ben Wolfram and her mother is artist Maria Wolfram.

In 2010, Joy Wolfram graduated with a master's degree in Biology from the University of Helsinki.

Joy Wolfram was a part-time researcher at the University's Institute of Biotechnology.

Joy Wolfram was an Amgen Scholar and she participated in a research at Karolinska Institute in 2009 regarding a novel protein that increases the migration of cancer cells.

Joy Wolfram has been a visiting scholar at the Department of Molecular and Cellular Biology Research, Sunnybrook Health Sciences Centre, Toronto, Canada, in 2010, investigating antiangiogenic receptor tyrosine kinase inhibitors.

Joy Wolfram began working as a research fellow for cancer and nanomedicine at the Houston Methodist Hospital in 2011.

Joy Wolfram had come up with strategies for modulating the immune system to allow accurate drug delivery to tumors, particularly through the use of chloroquine or through the body's own nanoparticles.

Joy Wolfram was named Finnish Expatriate of the Year in 2021.

Joy Wolfram is an advocate for increasing diversity in science, especially with underrepresented gender and racial minorities.